Citations

Mayo Clinic

Clear

189 citation(s) found for "Yu, Karina".

Abstract 12508: Tuning the Heart Rate Recovery For Age
Sydó, Tibor, Carta, Karina Auristela Gonzalez, Murphy, Joseph G. , Allison, Thomas G. , Sydó, Nóra , Merkely, Béla

Circulation | April 23, 2024 | Volume: 132 | Issue: suppl_3 | Pages: No page available

10.1161/circ.132.suppl_3.12508 Get It

Introduction: Exercise parameters such as peak heart rate (HR) are generally adjusted for age, whereas HR recovery is generally given as an absolute value: < 13 bpm at 1 minute post-peak exercise being abnormal. Hypothesis: We analyzed a large cohort of patients to determine the impact of age on HR recovery (HRRec) and if the prognostic performance of HRRec is improved by adjustment for age. Methods: Non-imaging exercise tests performed on patients aged 30-79 years from 1993 to 2010 were included. Patients with known cardiovascular diseases were excluded. Patients were assigned to 5 groups according to age: 30-39, 40-49, 50-59, 60-69, and 70-79. Mortality was reported according to HRRec during the first minute of active recovery using Cox regression analysis. Mortality was determined from Minnesota and National Death Indices. Results: 22,643 patients (64 % male) were included. The median HRRec in the age groups with IQR were as follows: 30-39: 20 [15-26]; 40-49: 19 [14-25]; 50-59: 18 [13-23]; 60-69: 15 [10-20]; and 70-79: 11 [6-16]. There were 1566 deaths (6.9%) over a mean follow-up of 11.8 ± 5.0 years. HRRec of 13 would fall at the 17 th percentile for patients 30-39 years old, but this increased to the 20 th , 27 th , 40 th , and 60 th percentiles with increasing age group. The mortality in age groups according to HRRec is shown in the Figure. For age groups 30-39 and 40-49, the hazard ratio for mortality at a HRRec of 11-12 bpm (i.e. just below the standard of 13) versus patients with a HRRec of ≥ 20 bpm was > 2.0. For age 50-59 and 60-69, however, a HRRec of < 11 bpm is necessary to obtain a doubling of risk, and for age 70-79 a HRRec of < 9 bpm is necessary. Conclusions: HRRec decreases significantly with age. The performance of abnormal HRRec defined as < 13 bpm is inconsistent across age groups. To standardize the ability of HRRec to identify at least a 2.0-fold increased risk, lowering the cup-point to < 11 bpm for ages 50-59 and 60-69 and < 9 bpm for age 70-79 is required.
Abstract 12496: A New Arrhythmic Threat to America. Chikungunya Myocarditis
Mendoza, Iván , Morr, Igor, Torres, Jaime R. , Gonzalez, Karina, Meza, Yolimar, Villalobos, Iris, Marques, Juan, Misticchio, Francesca, Vasquez, Rosalin, Morr, Carlos, Morr, Claudia

Circulation | April 23, 2024 | Volume: 132 | Issue: suppl_3 | Pages: No page available

10.1161/circ.132.suppl_3.12496 Get It

Background: The mosquito-borne Chikungunya virus infection is one of the most important emerging virus diseases globally. Local transmission has been found in the United States. There are very few published reports concerning the cardiac complications in general and less of arrhythmias in particular. Chikungunya can be fatal: there have been sudden deaths reports . Objective: To investigate arrhythmic complications of Chikungunya myocarditis. Methods: Prospective multicenter observational study of 280 patients with a Chikunguya infection from a Venezuelan Outbreak. Clinical evaluation, ECG, laboratory including virological evaluation and cardiac biomarkers, Echocardiogram, Holter and cardiac MRI procedures were carried out. Results: Of the 280 patients examined, 113 patients were male, with a mean age of 59 ± 9; 270 patients presented with fever and polyarthralgia and 85 developed palpitations. Arrhythmias occured in 45% of cases; they included bradyarrhythmias (33%), atrial and ventricular ectopic beats and tachyarrhythmias in which atrial fibrillation was observed in 19 cases. There were also ectopic atrial tachycardia and non sustained ventricular tachycardia, conduction disturbances and 3 cases of sudden death. Conclusion: Physicians should know that almost half of the Chikungunya patients will develop arrhythmias and manifest or silent myocarditis. In the proper epidemiological context, the triad of fever, polyarthralgia and new arrhythmia including bradiarrhythmias suggest Chikungunya Myocarditis.
Twin Pregnancy Complicated by Gestational Diabetes Mellitus: Maternal and Neonatal Outcomes
Das, Devika , Hegazi, Moustafa , Takawy, Marina, Pone, Karina, Vella, Adrian , Egan, Aoife M. , Takawy, Marina , Christie, Hannah E. , Pone, Karina A, Vella, Adrian , Egan, A M , Das, Devika , Takawy, Marina

Journal of the Endocrine Society | April 16, 2024 | Volume: 8 | Issue: 6 | Pages: No page available

10.1210/jendso/bvae075 | PMID 38698871 Get It

Abstract Context The risk of gestational diabetes mellitus (GDM) in twin pregnancies is more than double that of singleton pregnancies. Although twin pregnancies present unique challenges for fetal growth and prenatal management, the approach to GDM diagnosis and treatment is the same regardless of plurality. Data on pregnancy outcomes for individuals with GDM and a twin pregnancy are limited and conflicting. Objective To describe the maternal characteristics associated with GDM in twin pregnancies and to assess the associated pregnancy outcomes compared to twin pregnancies unaffected by GDM. Methods A retrospective cohort study was conducted at Mayo Clinic, Rochester, Minnesota, USA, and included predominantly Causasian women aged 18 to 45 years who received prenatal care for a twin pregnancy from 2017-2022. Maternal characteristics and a broad spectrum of pregnancy outcomes were evaluated. Universal GDM screening involved a 50 g oral glucose challenge test +/− a 100 g oral glucose tolerance test. Results GDM was diagnosed in 23% pregnancies (n = 104/452). Compared to those without, women with GDM had known risk factors including a higher prepregnancy body mass index (31.1vs 26.3 kg/m2; P &lt; .01) and a prior history of GDM (21.7 vs 5.9%; P &lt; .01). There were no differences in maternal pregnancy complications or neonatal outcomes between groups. Attendance at postpartum glucose testing among women with GDM was poor at 27.9% (29/104). Conclusion These data suggest that women with twin pregnancies share a similar GDM risk profile to those with singleton pregnancies and provide reassuring evidence that current management for GDM twin pregnancies produces similar outcomes to twin pregnancies without GDM.
An adult with cystathionine beta-synthase deficiency, camptodactyly-arthropathy-coxa vara-pericarditis syndrome, and deafness: A case report
Donis, Karina Carvalho , Kalil, Marco Antônio Baptista, Poswar, Fabiano de Oliveira , Kohem, Charles Lubianca , Poloni, Soraia , Borsatto, Taciane , Pinheiro, Franciele Cabral , Schwartz, Ida Vanessa Döederlein , de Oliveira Poswar, Fabiano , Pinheiro, Franciele Cabral , Schwartz, Ida Vanessa Doederlein , Kok, Fernando , Vairo, Filippo Pinto e

Genetics and Molecular Biology | April 8, 2024 | Volume: 47 | Issue: 1 | Pages: No page available

10.1590/1678-4685-gmb-2022-0335 | PMID 38593426 Get It

Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty Delphi
Tapper, Elliot B. , Shah, Rajesh P. , Emamaullee, Juliet , Poston, Jacqueline N. , Soto, Robin J., Pillai, Anjana , Reyner, Karina, Mehta, Shivang , Ghabril, Marwan , Morgan, Timothy R. , Caldwell, Stephen H. , Ghabril, Marwan S , Warner, Matthew A. , Dunbar, Nancy M. , Sholzberg, Michelle , Sarwar, Ammar

Hepatology | April 1, 2024 | Volume: 80 | Issue: 2 | Pages: 488-499

10.1097/hep.0000000000000856 | PMID 38557474 Get It

Patients with cirrhosis have abnormal coagulation indices such as a high international normalized ratio and low platelet count, but these do not correlate well with periprocedural bleeding risk. We sought to develop a consensus among the multiple stakeholders in cirrhosis care to inform process measures that can help improve the quality of the periprocedural management of coagulopathy in cirrhosis. We identified candidate process measures for periprocedural coagulopathy management in multiple contexts relating to the performance of paracentesis and upper endoscopy. An 11-member panel with content expertise was convened. It included nominees from professional societies for interventional radiology, transfusion medicine, and anesthesia as well as representatives from hematology, emergency medicine, transplant surgery, and community practice. Each measure was evaluated for agreement using a modified Delphi approach (3 rounds of rating) to define the final set of measures. Out of 286 possible measures, 33 measures made the final set. International normalized ratio testing was not required for diagnostic or therapeutic paracentesis as well as diagnostic endoscopy. Plasma transfusion should be avoided for all paracenteses and diagnostic endoscopy. No consensus was achieved for these items in therapeutic intent or emergent endoscopy. The risks of prophylactic platelet transfusions exceed their benefits for outpatient diagnostic paracentesis and diagnostic endosopies. For the other procedures examined, the risks outweigh benefits when platelet count is >20,000/mm 3 . It is uncertain whether risks outweigh benefits below 20,000/mm 3 in other contexts. No consensus was achieved on whether it was permissible to continue or stop systemic anticoagulation. Continuous aspirin was permissible for each procedure. Clopidogrel was permissible for diagnostic and therapeutic paracentesis and diagnostic endoscopy. We found many areas of consensus that may serve as a foundation for a common set of practice metrics for the periprocedural management of coagulopathy in cirrhosis.
High Resting Coronary Flow Velocity by Echocardiography Is Associated With Worse Survival in Patients With Chronic Coronary Syndromes
Cortigiani, Lauro , Gaibazzi, Nicola , Ciampi, Quirino , Rigo, F , Rodríguez‐Zanella, Hugo , Wierzbowska‐Drabik, Karina , Kasprzak, Jarosław D. , Arbucci, Rosina , Lowenstein, Jorge , Zagatina, A , Bartolacelli, Ylenia , Picano, Eugenio , group, the Stress Echo 2030 study, Rigo, Fausto , Zagatina, Angela , Gregori, Dario , Carerj, Scipione , Pepi, Mauro , Pellikka, Patricia A , Picano, Eugenio , Ciampi, Quirino , Wierzbowska-Drabik, Karina , Kasprzak, Jaroslaw D , Gaibazzi, Nicola , Arbucci, Rosina , Rodriguez-Zanella, Hugo , Pellikka, Patricia A. , group, the Stress Echo 2030 study

Journal of the American Heart Association | February 16, 2024 | Volume: 13 | Issue: 4 | Pages: No page available

10.1161/jaha.123.031270 | PMID 38362899 Get It

Background Resting coronary flow velocity (CFV) in the mid‐distal left anterior descending coronary artery can be easily assessed with transthoracic echocardiography. In this observational study, the authors sought to assess the relationship between resting CFV, CFV reserve (CFVR), and outcome in patients with chronic coronary syndromes. Methods and Results In a prospective multicenter study design, the authors retrospectively analyzed 7576 patients (age, 66±11 years; 4312 men) with chronic coronary syndromes and left ventricular ejection fraction ≥50% referred for dipyridamole stress echocardiography. Recruitment (years 2003–2021) involved 7 accredited laboratories, with interobserver variability <10% for CFV measurement at study entry. Baseline peak diastolic CFV was obtained by pulsed‐wave Doppler in the mid‐distal left anterior descending coronary artery. CFVR (abnormal value ≤2.0) was assessed with dipyridamole. All‐cause death was the only end point. The mean CFV of the left anterior descending coronary artery was 31±12 cm/s. The mean CFVR was 2.32±0.60. During a median follow‐up of 5.9±4.3 years, 1121 (15%) patients died. At multivariable analysis, resting CFV ≥32 cm/s was identified by a receiver operating curve as the best cutoff and was independently associated with mortality (hazard ratio [HR], 1.24 [95% CI, 1.10–1.40]; P <0.0001) together with CFVR ≤2.0 (HR, 1.78 [95% CI, 1.57–2.02]; P <0.0001), age, diabetes, history of coronary surgery, and left ventricular ejection fraction. When both CFV and CFVR were considered, the mortality rate was highest in patients with resting CFV ≥32 cm/s and CFVR ≤2.0 and lowest in patients with resting CFV <32 cm/s and CFVR >2.0. Conclusions High resting CFV is associated with worse survival in patients with chronic coronary syndromes and left ventricular ejection fraction ≥50%. The value is independent and additive to CFVR. The combination of high resting CFV and low CFVR is associated with the worst survival.
In Vivo Generation of Functional CD19 CAR-T Cells Using a Serum-Stable CD3-Targeted Lentiviral Vector
Nenavath, Gopal Naik, Moy, Melissa , Ziegler, Christopher M. , Alía, Miguel A Muñoz, Peng, Kah-Whye , Krotova, Karina Y. , Packiriswamy, Nandakumar , Vandergaast, Rianna

Blood | December 1, 2023 | Volume: 142 | Issue: Supplement 1 | Pages: 767-767

10.1182/blood-2023-186992 Get It

The high cost and complexity of CAR-T therapy has spurred efforts to generate CAR-T cells directly within patients via systemic infusion of serum-stable lentiviral vector particles that target T cells in situ for CAR transgene delivery. To ensure effective in vivo delivery, these vectors need to show resistance to neutralization by human serum, demonstrate transduction specificity for T cells, and support subsequent expansion of CAR-T cells. Lentiviral vectors (LV) pseudotyped with VSV G-glycoprotein (G-WT) transduce target cells via the LDL receptor (LDLR), which is ubiquitously expressed at variable levels and is upregulated on activated T cells. G-WT LVs are widely used to generate therapeutic CAR-T cells ex vivo, following purification and ex vivo activation of the T cells. To generate LVs capable of targeting circulating T cells in vivo, we utilized rational engineering of the VSV-G glycoprotein to design a G-CD3. This modified G protein avoids LDLR recognition, incorporates a CD3-specific single-chain antibody for targeted recognition of T cells, and minimizes LV particle inactivation upon exposure to human serum. G-CD3 LVs were shown to target and transduce resting T cells in peripheral blood mononuclear cell (PBMC) cultures with very high efficiency. The G-CD3 LVs powerfully activated T cells, evident from their increased CD25 expression, and the infection was not hindered in the presence of fresh, complement-active human serum (25%). Additionally, G-CD3 LVs efficiently transduced T cells in fresh human whole blood without apparent off-target transduction of non-T cell lineages. In vivo evaluation of G-CD3 LV efficiency was performed in humanized NSG mice by intravenous (IV) or intraperitoneal (IP) delivery of G-CD3 LVs encoding anti-CD19 CAR and GFP transgenes. Both IV and IP delivery of G-CD3 LV led to in vivo CAR T cell generation with peak levels of 17% of total circulating human CD45+ cells on day 21 post vector administration. The in vivo generated CD19-CAR-T cells were fully functional as evidenced by the disappearance of endogenous human CD19+ B cells from peripheral blood. Tissue analysis of spleen, bone marrow, and liver at the time of sacrifice (day 39 post LV injection), showed anti-CD19 CAR-T in all three tissues accompanied by an absence or dramatic reduction in tissue-resident human CD19+ B cells. In contrast, CAR-T cells were not detected at any time point in humanized NSG mice injected with G-WT LV, regardless of whether the virus was administered IV or IP. In summary, these data highlight the potential applicability of fully retargeted, serum stable LVs for in vivo gene delivery or genome editing, offering promising prospects for future human gene therapy applications.
Biventricular dysfunction and lung congestion in post-COVID patients: a speckle tracking and stress lung echocardiography analysis
Pandang, S, Tagliamonte, Ercole , Djordievic-Dikic, Ana, Rigo, Fausto , D’Andrea, Antonello , Boshchenko, A , Colonna, Paolo , Wierzbowska‐Drabik, Karina , Zagatina, A , Cocchia, Rosangela , Ciampi, Quirino

European Heart Journal | November 11, 2023 | Volume: 44 | Issue: Supplement_2 | Pages: No page available

10.1093/eurheartj/ehad655.107 Get It

Abstract Background Cardiovascular abnormalities have been observed in half of all COVID-19 patients in the acute phase of the infection. Additionally, 10-35% of these patients have various long-term symptoms diagnosed with post-acute sequelae of COVID-19 (PASC). Aim of this study was to evaluate the role of exercise stress echocardiography (ESE) with an integrated approach, inclusive of Speckle-Tracking Echocardiography (STE) with Myocardial Work (MW) analysis in the evaluation of patients after COVID infection. Methods We prospectively recruited a population of 370 post-COVID 19 patients (Group 1) (225 males; 55.8 ±8.3 years), and of 250 age- and sex-comparable healthy controls (Group 2). In Standard Doppler echocardiography, STE and MW analyses and lung ultrasound at rest and at peak supine-bicycle ESE were performed. Results Left ventricular (LV) wall thickness, diameters and mass index were comparable between the two groups. Both LV ejection fraction (EF) and right ventricular (RV) functional indexes (TAPSE and Tissue Doppler S’ wave) at rest did not show differences between the two groups. Conversely, baseline LV GLS (-16.2±2.8 vs. –20.4±3.3 %; p&lt;0.01), MW efficiency (88.8±3.2 vs. 93.2±3.3 %; p&lt;0.001), and RV strain (-16.4±2.8 vs. –20.4±4.3 %; p&lt;0.01), were significantly reduced in Group 1. Also pulmonary artery systolic pressures (PASP) (33.5±3.8 vs. 24.6±3.1 mmHg; p&lt;0.001), and LV E/e’ ratio were significantly increased in COVID group, while B-lines ( ≥ 2) at rest were found in 25.3% of Group 1 and 5.1% of Group 2 (p &lt; 0.001). During effort, COVID patients showed reduced exercise time and exercise capacity (&lt;0.001). Values of LVEF, RV strain and LV GLS (all with p value &lt;0.01) and MWE (p&lt;0001) were much lower in COVID patients when compared to Group 2. Additionally, COVID patients showed at peak effort an increased LV E/e’ ratio, pulmonary pressures and B-lines by lung ultrasound (all p &lt;0.001). Multivariable analysis detected independent associations of baseline GLS and MWE with maximal workload (watts reached), LV E/e’ ratio and B-lines during effort (p&lt;0.001), stronger than the association of LVEF with the same functional parameters (p&lt;0.01). What’s more, RV strain (p&lt;0.001) was significantly associated with PASP levels at peak effort. Conclusions In post-COVID patients, biventricular involvement with impairment of LV and RV systolic function is frequent, missed by conventional indices such as EF or TAPSE, and detected by more sensitive STE indices such as LV-GLS, ME, and RV-strain. These alterations are functionally significant and associated with shorter exercise -time, more pulmonary hypertension, and greater pulmonary congestion during stress.
S355 Targeting the Sugar Code: Serum Glycoproteome Profiling for Early Detection of Advanced Adenoma and Colorectal Cancer
Liu, Julia J., Pohl, Heiko , Desai, Khushbu, Chandrasekar, Dharini, Ramachandran, Prasanna , Islas-Rios, Karina, Shipman, Richard David , Serie, Daniel, Hommes, Daniël W. , Gupta, Samir , Shaukat, Aasma , Ding, Nik S. , Guerrier, Christina , Čaval, Tomislav , Campbell, Matthew P. , Dhar, Chirag , Xu, Gege , Schwarz, Flavio , Dekker, Evelien , Wallace, Michael B. , May, Folasade P.

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S257-S257

10.14309/01.ajg.0000951060.45550.25 Get It

Risk of malignancy assessment of the different cytologic categories in respiratory cytology samples according to the new guidelines of the Papanicolaou Society of Cytopathology
Ardor, Gokce Deniz , Ahmed, Momin , Hanna, Karina, Ibanoglu, Onur, Nassar, Aziza , Nassar, Aziza

Diagnostic Cytopathology | October 9, 2023 | Volume: 52 | Issue: 1 | Pages: 16-21

10.1002/dc.25234 | PMID 37811689 Get It

AbstractBackgroundCytology is extremely important for diagnosis of lung carcinoma and the Papanicolaou Society of Cytopathology (PSC) had proposed a new classification system for respiratory cytology for better communication between physicians and better patient management. The objective of this study is to analyze our samples in accordance with this classification and to evaluate the diagnostic accuracy of various cytologic techniques and to assess the risk of malignancy.MethodsEight hundred and twenty respiratory cytology specimens (FNA, BAL, washing, brushing, sputum) collected between 2019 and 2022 were classified according to the PSC system and the risk of malignancy was assessed for each category using follow‐up surgical samples. Sensitivity, specificity, and accuracy rates were determined based on a categorial approach, according to a similar study.ResultsThe data of 820 respiratory cytology specimens from 576 patients were analyzed. 2.6% of these were non‐diagnostic, 64.1% were NM, 5% were AC, 0.4% were N‐B‐LG, 4% were SM and 23.9% were ML. The risk of malignancy for each diagnostic category were: 42.8% for non‐diagnostic, 31.2% for NM, 43.9% for AC, 87.9% for SM, 94.3% for ML. Sensitivity and specificity was calculated using only the malignant cases considered as positive tests and was 45.57% and 97.34% respectively.ConclusionOur results correlated with the PSC system, and it was considered useful in clinical practice. However, more studies should be performed to evaluate the usefulness of this system. The ROMs of each category and the impact of different techniques should be further studied.